Press Release

Proliferation Incidence of Chronic Diseases is Propelling the Growth for Asia-Pacific Electrophysiology Mapping and Ablation Devices Market

The Asia-Pacific Electrophysiology Mapping and Ablation Devices market is growing at a high rate owing to the factors such as booming aging population, rising funding in R&D activities for the development of targeted drugs and surging government investment towards the development of healthcare infrastructure. Besides this, increasing sedentary lifestyles, escalating smoking and consumption of alcohol along with burgeoning incidence of chronic diseases are some of the factors proliferating the growth of the market in the forecasted period.

According to MarkNtel Advisors’ research report “Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Analysis, 2020”, the Asia-Pacific Electrophysiology Mapping and Ablation Devices market is anticipated to grow at a considerable CAGR during 2020-25. Based on Type, Ablation catheters grabbed the majority market share in 2019. The growth of the segment is attributed to rising application of electrophysiology ablation catheter for cardiac cells to remove malignant tumours and lesions.

“Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Electrophysiology Mapping and Ablation Devices providers across the region. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.      

China Grabbed the Largest Market Share

China grabbed the largest market share in the Asia-Pacific Electrophysiology Mapping and Ablation Devices market in 2019. The surging demand for cardiac rhythm management device, rise in cardiovascular disorders among people, and growing elderly population. Moreover, growing awareness of syndromes such as atrial fibrillation, WPW and atrial flutter, escalating number for screening techniques and snowballing spending towards healthcare infrastructure are strongly contributing towards the market growth of the Electrophysiology Mapping and Ablation Devices in the forthcoming period as revealed by the MarkNtel Advisors’ research report “Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Analysis, 2020”. 

According to MarkNtel Advisors’, the key players with a considerable market share in the Asia-Pacific Electrophysiology Mapping and Ablation Devices market Abbott, Biotronic Inc., Olympus Corporation., Arthrex Inc., Siemens Helathineers AG, Boston Scientific Corporation, STARmed Company Ltd., Medtronic, GE Healthcare, Japan Lifeline Co. Ltd. etc.

Market Segmentation:

1. By Type (Conventional, Advanced, Ultrasound, Ablation Catheters)
2. By Application (AF (Atrial Fibrillation), PVC (Premature Ventricular Contractions), AVNRT (Atrioventricular nodal reentry tachycardia), WPW (Wolff-Parkinson-White), Atrial Flutter, AV Re-Entrant Tachycardia, AV Nodal Tachycardia, Others)
3. By End-User (Hospitals, Diagnostics Centre, Clinics, Others)
4. By Country (China, Japan, South Korea, Australia, India),
5. By Company (Abbott, Biotronic Inc., Olympus Corporation., Arthrex Inc., Siemens Helathineers AG, Boston Scientific Corporation, STARmed Company Ltd., Medtronic, GE Healthcare, Japan Lifeline Co. Ltd. etc.)

Key questions answered in the study

1. What are the current and future trends of the Electrophysiology Mapping and Ablation Devices industry?
2. How the industry has been evolving in terms of end-user demand and application areas?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Electrophysiology Mapping and Ablation Devices industry?
5. What is the customer orientation, purchase behavior, and expectations from the Electrophysiology Mapping and Ablation Devices firms across various regions?